Results 161 to 170 of about 33,833 (238)

Rifampicin-resistant tuberculosis in Spain. [PDF]

ERJ Open Res
García-García JM, Rodrigo-Sanz T, Gullón-Blanco JA, Casas García X, Millet JP, Quirós Fernández S, Martínez Lirola MJ, Mangas Moro A, Domínguez Castellano Á, Navas Elorza E, Nieto Marcos M, Arasa Panisello F, Bermúdez Ruiz P, García Cabrera M, Sanz Herrero F, Suárez Toste I, Urrelo Cerrón LA, Espiau Guarner M, Soriano Arandes A, Arias Guillén M, Cebrián Gallardo JJ, García-Fuertes JA, Pérez-Jacoiste Asín MA, Somoza González M, Palacios Gutiérrez JJ, Alcaide F, Samper Blasco S, Tabernero Huguet E, Caylà JA, Ruiz Manzano J, Caminero Luna JA, Working Group on Rifampicin Resistant Tuberculosis of the Tuberculosis Research Programme (PII-TB) SEPAR .   +31 more
europepmc   +1 more source

Protocol for a phase 2, partially blinded, randomized trial assessing the safety and efficacy of sorfequiline or bedaquiline in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear-positive pulmonary tuberculosis (NC-009). [PDF]

Trials
Olugbosi M, Beumont M, Lombard L, Nedelman J, Timm J, Black T, Bruning-Barry R, Hickman D, Lombardi A, Betteridge M, Egizi E, Marcopulos L, Henderson J, Seidel S, Foraida S, Benhayoun M, Sun E.   +16 more
europepmc   +1 more source

Safety and outcome of bedaquiline and delamanid-based longer oral regimen in Indian children less than 5 years with drug-resistant tuberculosis. [PDF]

Lung India
Shah I, Ansari R, Gandhi DN, Jain S, Puri V, Shah D, Mattoo SK, Bodhanwala M.   +7 more
europepmc   +1 more source

The quantity and severity of adverse drug reactions experienced by patients with multi-drug resistant tuberculosis in the Ugu District. [PDF]

BMC Infect Dis
Ramasir S, Oosthuizen F, Bangalee V.
europepmc   +1 more source

Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. [PDF]

Emerg Infect Dis
Seung KJ, Asfaw M, Kunda M, Maama-Maime LB, Makaka J, Mofolo M, Mpinda S, Ndayizigiye M, Omar SV, Prasad P, Rupasinghe P, Yarbrough C, Oyewusi L.   +12 more
europepmc   +1 more source

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]

BMC Infect Dis
Schreurs H, Dejaegher J, Decroo T, André E, Lorent N, Henckaerts L.   +5 more
europepmc   +1 more source

Management of adverse events in TB care and active TB drug safety monitoring. [PDF]

Breathe (Sheff)
Ma'aruf SY, Sharma A, Fox S, Duarte R, Lange C, Tiberi S.   +5 more
europepmc   +1 more source

Bedaquiline treatment for a case of nontuberculous mycobacterial pulmonary disease following initial treatment failure. [PDF]

Quant Imaging Med Surg
Dai G, Yin C, Gao W, Wang T, Tang X, Chen S, Zeng Y.   +6 more
europepmc   +1 more source

Bedaquiline combined with clofazimine as salvage therapy for 11 patients with nontuberculous mycobacterial lung disease. [PDF]

BMC Infect Dis
Yao L, He Y, Yang J, Zheng X, Shi X, Wei W, Yang G, Ying R, Sha W.   +8 more
europepmc   +1 more source

Bioequivalence Study of Bedaquiline and Sirturo^® in Healthy Chinese Subjects Under Fasting and Postprandial Conditions: A Randomized, Open-Label, Single-Dose, Crossover Trial. [PDF]

Drugs R D
Li Y, Wu Y, Cai S, Huang X, Ye L, Wang L, Zhang Y, Wang Y, Tao X.   +8 more
europepmc   +1 more source